BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 22672822)

  • 1. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
    Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3β/NF-κB-mediated protective signaling in mice.
    Xia Y; Rao J; Yao A; Zhang F; Li G; Wang X; Lu L
    Eur J Pharmacol; 2012 Dec; 697(1-3):117-25. PubMed ID: 23051669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic preconditioning increases GSK-3β/β-catenin levels and ameliorates liver ischemia/reperfusion injury in rats.
    Yan Y; Li G; Tian X; Ye Y; Gao Z; Yao J; Zhang F; Wang S
    Int J Mol Med; 2015 Jun; 35(6):1625-32. PubMed ID: 25813855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
    Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF
    Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.
    Kaga S; Zhan L; Altaf E; Maulik N
    J Mol Cell Cardiol; 2006 Jan; 40(1):138-47. PubMed ID: 16288908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic postconditioning mediates cardioprotection via PI3K/GSK-3β/β-catenin signaling pathway in ischemic rat myocardium.
    Wu QL; Shen T; Shao LL; Ma H; Wang JK
    Shock; 2012 Aug; 38(2):165-9. PubMed ID: 22576003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of GSK-3beta decreases NF-kappaB-dependent gene expression and impairs the rat liver regeneration.
    Chen H; Yang S; Yang Z; Ma L; Jiang D; Mao J; Jiao B; Cai Z
    J Cell Biochem; 2007 Dec; 102(5):1281-9. PubMed ID: 17427960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flurbiprofen, a cyclooxygenase inhibitor, protects mice from hepatic ischemia/reperfusion injury by inhibiting GSK-3β signaling and mitochondrial permeability transition.
    Fu H; Chen H; Wang C; Xu H; Liu F; Guo M; Wang Q; Shi X
    Mol Med; 2012 Sep; 18(1):1128-35. PubMed ID: 22714712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
    Neelam S; Brooks MM; Cammarata PR
    Mol Vis; 2014; 20():1758-75. PubMed ID: 25593505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
    Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
    Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of AKT1/GSK-3β/β-Catenin-TRIM11/Survivin Pathway by Novel GSK-3β Inhibitor Promotes Neuron Cell Survival: Study in Differentiated SH-SY5Y Cells in OGD Model.
    Darshit BS; Ramanathan M
    Mol Neurobiol; 2016 Dec; 53(10):6716-6729. PubMed ID: 26660108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic postconditioning activates the Wnt/β-catenin pathway and protects against transient global cerebral ischemia through Dkk1 Inhibition and GSK-3β inactivation.
    Zhan L; Liu D; Wen H; Hu J; Pang T; Sun W; Xu E
    FASEB J; 2019 Aug; 33(8):9291-9307. PubMed ID: 31120770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrosulfide attenuates acute myocardial ischemic injury through the glycogen synthase kinase-3β/β-catenin signaling pathway.
    Ge N; Liu C; Li G; Xie L; Zhang Q; Li L; Hao N; Zhang J
    Int J Mol Med; 2016 May; 37(5):1281-9. PubMed ID: 27035393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway.
    Sun J; Yan P; Chen Y; Chen Y; Yang J; Xu G; Mao H; Qiu Y
    Diagn Pathol; 2015 Jun; 10():72. PubMed ID: 26088648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Akt/GSK-3beta/beta-catenin signaling pathway is involved in survival of neurons after traumatic brain injury in rats.
    Zhao S; Fu J; Liu X; Wang T; Zhang J; Zhao Y
    Neurol Res; 2012 May; 34(4):400-7. PubMed ID: 22643085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen sulfide preconditioning protects rat liver against ischemia/reperfusion injury by activating Akt-GSK-3β signaling and inhibiting mitochondrial permeability transition.
    Zhang Q; Fu H; Zhang H; Xu F; Zou Z; Liu M; Wang Q; Miao M; Shi X
    PLoS One; 2013; 8(9):e74422. PubMed ID: 24058562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
    Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L
    Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulates proliferation of HAPI microglia by affecting the Akt/GSK-3β/cyclin D1 signaling pathway.
    Xu G; Li Y; Yoshimoto K; Wu Q; Chen G; Iwata T; Mizusawa N; Wan C; Nie X
    Toxicol Lett; 2014 Jan; 224(3):362-70. PubMed ID: 24231000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
    Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.